GlassScriptPhysician profile
Yinling Pan
NPI 1912663980
$2,961.66
in general payments reported to CMS, 2019-2025
17 companies · $1,261 in 2025
The $1,261 reported for 2025 was more than what 88% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.67 · 2022: $597 · 2023: $447 · 2024: $612 · 2025: $1,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,320.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $551.69 | 2022-2025 | Ibsrela |
| Madrigal Pharmaceuticals | $404.93 | 2024-2025 | Rezdiffra, Resmetirom |
| Gilead Sciences, INC. | $390.11 | 2022-2025 | |
| Abbvie INC. | $383.46 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $305.90 | 2022-2025 | Xifaxan |
| Phathom Pharmaceuticals, INC. | $236.25 | 2024-2025 | Voquezna |
| Novartis Pharmaceuticals Corporation | $134.01 | 2024-2025 | |
| Grifols USA, LLC | $125.00 | 2024 | Gamunex-C |
| Intra-Sana Laboratories | $100.00 | 2022 | |
| Nestle Healthcare Nutrition INC. | $61.23 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $58.48 | 2025 | Amvuttra |
| Genzyme Corporation | $49.67 | 2025 | |
| Paratek Pharmaceuticals, INC. | $48.37 | 2025 | Nuzyra |
| Lilly USA, LLC | $40.40 | 2024-2025 | Kisunla |
| Melinta Therapeutics, LLC | $24.37 | 2025 | Orbactiv, Kimyrsa, Rezzayo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $23.94 | 2024 | |
| Lundbeck LLC | $23.85 | 2024 | Vyepti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yinling Pan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.